What Everglade Consulting does

Everglade Consulting (legal entity: EverGlade Consulting, LLC) is a privately held, U.S.-headquartered advisory firm that helps life sciences and technology innovators navigate the federal funding ecosystem from opportunity identification through post-award program closeout. Founded in 2020 and operating from Houston, TX and Washington, DC, the firm is organized around a four-stage lifecycle — Strategize, Propose, Negotiate, Execute — delivered through dedicated practices across HHS (BARDA, ARPA-H, NIAID, ASPR IBx), DoD (DARPA, DTRA, DIU, JPEO-CBRND consortium vehicles MTEC, MCDC, CWMD), civilian energy agencies (DOE Loan Programs Office, ARPA-E, EERE), and the International Development Finance Corporation. The firm has stated it has helped clients secure more than $3 billion in non-dilutive federal funding across agencies, with named engagements including up to $45M for GeoVax Labs (BARDA, 2024) and up to $18.3M for Landmark Bio (ARPA-H, 2026).

The firm's underlying capability stack rests on regulatory fluency in FAR, DFARS, CAS, and federal acquisition mechanisms (BAAs, RFPs, OTAs, cooperative agreements), combined with a senior bench of PhD scientists, PMP-certified program managers, MBAs, and former government COTRs/Auditors. Its proprietary program infrastructure comprises standardized tools, templates, and processes built through repeated R&D program execution, packaged into a repeatable methodology marketed as "Boost Your Success Rate." Distribution is sales-led and direct: the firm runs a content-marketing engine (blog, solicitation alerts, LinkedIn, YouTube, PR Newswire distributions) feeding direct enterprise consultations with biotech, medtech, pharma, autonomous tech, AI/cybersecurity, energy, and academic research clients.

Everglade is bootstrapped and founder-owned (co-founders Eric Jia-Sobota and Jerry Jia-Sobota), with no disclosed venture or private equity rounds. Giacomo Apadula, Jr. was appointed CEO effective October 6, 2025, and Dr. Patrick Sims joined as Managing Consultant in April 2026, signaling a transition from founder-led to professionally-managed scale-up. Revenue is generated through customized, quote-based professional services engagements, typically structured as multi-year contracts tied to pursuit-and-execution milestones.

Name

Everglade Consulting

Legal name

EverGlade Consulting, LLC

Website

https://everglade.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

EverGlade Consulting is a privately held U.S. advisory firm that helps life sciences and technology innovators secure and execute non-dilutive federal funding across HHS, DoD, civilian science agencies, DOE, and DFC, offering a full Strategize-to-Execute lifecycle service.

Ownership category

akta.pro rank

Product category

Federal Funding Advisory Services

NAICS

Management Consulting Services (54161), Management, Scientific, and Technical Consulting Services (5416)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Risk, Compliance & Internal Controls Consulting (BPAHACAJ)

akta.pro secondary industry

Innovation, Product & R&D Consulting (BPAHACAM)

Keywords

• Federal funding advisory
• Life sciences consulting
• Government grant services
• Technology funding consulting
• Proposal development services

Headquarters

HQ city

Charleston

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Federal Funding Advisory Services: Professional consulting services for the full federal funding lifecycle including strategy, proposal pursuit, contract negotiations, and post-award execution and compliance support. Services are tailored to each client engagement with custom pricing based on scope and complexity.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Everglade Consulting provides professional advisory services that guide life sciences and technology innovators through the full federal funding lifecycle, including strategy, proposal pursuit, contract negotiations, and post-award execution and compliance support. The firm secures and executes high-risk, high-impact R&D funding programs across HHS, DoD, and civilian science and technology agencies. Service offerings are organized as Strategize, Propose, Negotiate, and Execute, with specialized advisory for agencies such as BARDA, ARPA-H, NIAID, DARPA, DTRA, DIU, DOE, and DFC.

Product overview

Everglade Consulting is a national advisory firm that provides strategic consulting services to help life sciences and technology innovators navigate the federal funding ecosystem. The company offers a comprehensive suite of advisory services organized around the federal funding lifecycle: Strategize, Propose, Negotiate, and Execute. Their service offerings are specialized by funding domain, including BARDA Funding Advisory, ARPA-H Funding Advisory, NIAID Funding Advisory, CPE CBRND Funding Advisory, DoD Agencies & Offices Advisory, Autonomous Technology Funding Advisory, Energy Funding Advisory, and DFC Loan Advisory. The firm supports clients across HHS, DoD, and civilian science and technology agencies, helping secure non-dilutive funding for high-risk, high-impact R&D programs.

Differentiator

Problem solved

Functional benefit

Products and services

• Strategize Services Federal funding pursuit strategy development including program fit validation, technical viability assessment, technology alignment to agency priorities, and ongoing federal landscape review, for organizations seeking non-dilutive R&D funding.
• Propose Services Proposal development and submission support including TechWatch meetings, concept papers, white papers, solution summaries, full proposal development, statement of work, work breakdown structure, technical approach, integrated master schedule, budget design, and subcontractor management, for clients pursuing federal funding.
• Negotiate Services Contract negotiation support including contract review and positioning, cost share and budget clarifications, response strategy development, and terms alignment and finalization, for clients negotiating federal awards.
• Execute Services Post-award program execution support including program oversight, risk and performance management, subcontractor and procurement oversight, financial and contract compliance with USG audit support, and project closeout, for clients executing federal awards.
• BARDA Funding Advisory Specialized advisory services for securing funding from the Biomedical Advanced Research and Development Authority (BARDA), supporting vaccine, therapeutic, and diagnostic development through BAAs, RFPs, and Other Transaction Agreements, for biotech and life sciences companies.
• ARPA-H Funding Advisory Advisory services for securing funding from the Advanced Research Projects Agency for Health (ARPA-H), including support for Innovative Solutions Openings (ISOs), Mission Office ISOs, and targeted research initiatives, for health-focused research organizations.
• NIAID Funding Advisory Advisory services for securing funding from the National Institute of Allergy and Infectious Diseases (NIAID), including grants, contracts, and cooperative agreements for infectious and immunologic disease research, for academic and biotech clients.
• JPEO CBRND Funding Advisory Advisory services for Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense funding opportunities, including MTEC, MCDC, and CWMD consortium programs, for biodefense and CBRN defense clients.
• DoD Agencies & Offices Funding Advisory Advisory services for Department of Defense funding including DARPA (synthetic biology, trauma care, biosciences), DTRA (biodefense technologies), DPA Title III (domestic production capabilities), and DIU (commercial technology adoption), for defense-oriented biotech and technology clients.
• Autonomous Technology Funding Advisory Advisory services for autonomous technology and AI funding including defense and security innovation (DARPA, DIU, JAIC), artificial intelligence R&D (NSF AI Institutes, DOE AI Grants), emerging technologies, cybersecurity, and unmanned systems, for AI, cybersecurity, and autonomous systems companies.
• Energy Funding Advisory Advisory services for energy innovation funding including DOE Loan Programs Office support, ARPA-E (energy technology RDT&E), EERE (energy efficiency and renewable energy), and Infrastructure Investment and Jobs Act programs, for clean energy and sustainable technology organizations.
• DFC Loan Advisory Advisory services for International Development Finance Corporation (DFC) loan programs supporting private sector investment in emerging markets, including healthcare, biotechnology, technology, advanced manufacturing, defense, infrastructure, and renewable energy sectors, for companies pursuing international expansion financing.

Quantifiable outcome

• $3B+ in non-dilutive federal funding secured across agencies
• +2 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Nine partnerships are on record, tiered core and minor.

• Landmark BiocoreStrategic or Co-development Partner · 21 April 2026Everglade guided Landmark Bio through the federal funding process including negotiations, project structuring, and financial planning to secure up to $18.3 million from ARPA-H's TRANSFORM-EV program for extracellular vesicle manufacturing.
• GeoVax LabscoreStrategic or Co-development Partner · 28 August 2024Everglade supported GeoVax Labs in securing up to $45 million in BARDA funding for next-generation COVID-19 vaccine development. The partnership included manufacturing support and Phase 2b clinical trial funding.
• IDBiologicscoreStrategic or Co-development PartnerEverglade manages technical and financial reporting processes for IDBiologics' federal award, allowing the client to focus on scientific research and discovery.
• AllucentminorStrategic or Co-development PartnerSupporting partner in GeoVax COVID-19 vaccine development with overall clinical evaluation value up to $388 million including additional support from Allucent.
• Medical Technology Enterprise Consortium (MTEC)minorOthersEverglade supports clients pursuing funding through MTEC, which focuses on accelerating development of medical technologies for military and civilian use in support of DTRA.
• Rapid Response Partnership Vehicle (RRPV) ConsortiumminorOthersJoint initiative with BARDA to promote R&D in response to pandemics or public health emergencies. Everglade helps clients access funding through this consortium vehicle.
• Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-C)minorOthersConsortium advancing biomanufacturing innovations to enhance production efficiency and scalability, with Everglade supporting client participation.
• Medical CBRN Defense Consortium (MCDC)minorOthersConsortium advancing development efforts to support DoD's medical, pharmaceutical, and diagnostic requirements related to CBRN defense.
• Countering Weapons of Mass Destruction Consortium (CWMD)minorOthersConsortium supporting DoD's ability to detect, prevent, and protect against WMD threats, with Everglade assisting client engagement.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• The Conafay Group: Life sciences-focused federal funding and SBIR/STTR advisory firm supporting biotech and medtech companies pursuing BARDA, NIH, and DoD awards. Direct head-to-head competitor in the federal grant advisory niche Everglade serves.
• Attain Partners: Federal management and technology consulting firm serving federal agencies and the contractors/innovators that serve them. Comparable scale and business model to Everglade, with overlap on grants, program management, and federal acquisition compliance.
• Catalyst Partners: Federal funding and government affairs consulting firm supporting clients pursuing grants and contracts across civilian and defense agencies. Comparable model: end-to-end proposal, award, and compliance support for federal R&D clients.
• Federal Science Partners: Specialized federal funding and grants advisory firm serving research institutions and life sciences innovators. Closely comparable niche: helps clients identify, pursue, and manage federal R&D awards with a similar relationship-driven, lifecycle-based service model.

Broad incumbents

• ICF International: Established public-sector consulting firm with deep federal health, energy, and environmental practices serving HHS, DoD, DOE, and other civilian agencies. Overlaps with Everglade on proposal support and program execution, though within a much broader portfolio.
• Cornerstone Government Affairs: Federal lobbying, funding, and appropriations advisory firm supporting life sciences, technology, and defense clients in Washington, DC. Comparable target market (federal funding seekers) and DC-centric relationship model, though with a stronger lobbying/appropriations focus.
• Booz Allen Hamilton: Top-tier federal consulting firm with a large defense, health, and civil portfolio serving DoD, HHS, intelligence, and civilian agencies. Competes for federal R&D advisory mandates, though typically at much larger engagement scale than Everglade.
• Guidehouse (Public Sector): Large management consulting firm with a substantial public sector and federal health practice (formerly PwC's public sector business). Overlaps with Everglade on HHS, DoD, and civilian advisory work but at vastly greater scale and broader scope.
• Leidos: Major federal contractor with Health & Civil and Defense solutions serving HHS, DoD, DOE, and intelligence agencies. Competes with Everglade in federal health and life sciences program support, typically as a large-systems integrator rather than a niche advisor.
• CALIBRE Systems: Federal management and program execution consultancy supporting DoD, HHS, and civilian agencies. Comparable on program management, compliance, and post-award execution services delivered to federal R&D clients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UC4VBWgOaM4ms4MGg7M3_PvQ
• LinkedInlinkedin.com/company/evergladeconsulting
• Xx.com/evergladeinc
• Facebookfacebook.com/EverGladeInc

Revenue estimate

Valuation estimate

Number of profiles

Profiles21 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Everglade Consulting